Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Caladrius Biosciences Inc (F: 8NE2)

 
8NE2 Technical Analysis
5
As on 14th Sep 2022 8NE2 STOCK Price closed @ 0.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.02 & Strong Sell for SHORT-TERM with Stoploss of 1.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

8NE2STOCK Price

Open 0.50 Change Price %
High 0.72 1 Day -0.11 -22.00
Low 0.39 1 Week -0.12 -23.53
Close 0.39 1 Month -0.10 -20.41
Volume 38880 1 Year -1.20 -75.47
52 Week High 1.59 | 52 Week Low 0.39
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
8NE2
Daily Charts		 8NE2
Intraday Charts		 Whats New @
Bazaartrend		 8NE2
Free Analysis
 
8NE2 Important Levels Intraday
RESISTANCE1.03
RESISTANCE0.82
RESISTANCE0.70
RESISTANCE0.57
SUPPORT0.21
SUPPORT0.08
SUPPORT-0.04
SUPPORT-0.25
 
8NE2 Forecast May 2024
Share
4th UP Forecast0.85
3rd UP Forecast0.7
2nd UP Forecast0.61
1st UP Forecast0.52
1st DOWN Forecast0.26
2nd DOWN Forecast0.17
3rd DOWN Forecast0.08
4th DOWN Forecast-0.07
 
8NE2 Weekly Forecast
4th UP Forecast0.79
3rd UP Forecast0.66
2nd UP Forecast0.58
1st UP Forecast0.50
1st DOWN Forecast0.28
2nd DOWN Forecast0.20
3rd DOWN Forecast0.12
4th DOWN Forecast-0.01
 
8NE2 Forecast2024
4th UP Forecast2.63
3rd UP Forecast1.91
2nd UP Forecast1.47
1st UP Forecast1.02
1st DOWN Forecast-0.24
2nd DOWN Forecast-0.69
3rd DOWN Forecast-1.13
4th DOWN Forecast-1.85
 
 
8NE2 Other Details
Segment EQ
Market Capital 56917656.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
8NE2 Address
8NE2
 
8NE2 Latest News
 
Your Comments and Response on Caladrius Biosciences Inc
 
8NE2 Business Profile
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service